Research Topics
| G J KapadiaSummaryAffiliation: Howard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugsG J Kapadia
Laboratory of Natural Drug Products, Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, 2300 4th Street, NW Washington, DC 20059, USA
Cancer Lett 161:221-9. 2000....
Aminonaphthoquinones--a novel class of compounds with potent antimalarial activity against Plasmodium falciparumG J Kapadia
Laboratory of Natural Drug Products, Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, 2300 4th Street, NW, Washington, DC 20059, USA
Pharmacol Res 43:363-7. 2001..In general, 2-amino-1,4-naphthoquinone analogs and the 4-amino-1,2-napthoquinone analog showed promising antimalarial activity in the bioassay. In contrast, a number of 2-hydroxy-1,4-naphthoquinones and dimeric quinones were less active...
Inhibitory effect of herbal remedies on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activationGovind J Kapadia
Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, 2300 4 thStreet, NW, Washington, DC 20059, USA
Pharmacol Res 45:213-20. 2002....
Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesisGovind J Kapadia
Laboratory of Natural Drug Products, Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, 2300 4th Street NW, Washington, DC 20059, USA
Pharmacol Res 45:499-505. 2002..The observed chemopreventive effect of these products particularly warrants more attention since they already exist in the population with no known adverse effects...
Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetrootGovind J Kapadia
Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, 2300 4th Street, NW, Washington, DC 20059, USA
Pharmacol Res 47:141-8. 2003....
Chemopreventive activities of etodolac and oxyphenbutazone against mouse skin carcinogenesisGovind J Kapadia
Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, Washington, DC 20059, USA
Bioorg Med Chem Lett 20:2546-8. 2010..7 nmol of TPA was significantly inhibited by oral administration of 0.0025% OPB. The results demonstrate that OPB is a potent cancer chemopreventive agent in the highly sensitive in vivo mouse test model we used...
Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell linesGovind J Kapadia
Department of Pharmaceutical Sciences, Howard University, Washington, DC 20059, USA
Anticancer Agents Med Chem 11:280-4. 2011..Further studies are needed to evaluate the chemopreventive potentials of the beetroot extract when used alone or in combination with doxorubicin to mitigate the toxic side-effects of the latter...
Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis modelsMagnus A Azuine
Laboratory of Natural Drug Products, Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, 2300 4th Street, NW, Washington, DC 20059, USA
Pharmacol Res 49:161-9. 2004....
Evaluation of skin cancer chemoprevention potential of sunscreen agents using the Epstein-Barr virus early antigen activation in vitro assayG J Kapadia
Department of Pharmaceutical Sciences, Howard University, Washington, DC 20059, USA
Int J Cosmet Sci 35:143-8. 2013..The results call for a comprehensive analysis of skin cancer chemoprevention potential of currently used UV sunscreen agents around the globe to identify those with the best clinical profile...
